Octave

Octave has been recognized as the “Best Care Management Platform” in the 8th Annual MedTech Breakthrough award program. The recognition is a testament to our success in delivering actionable insights in a precision medicine solution for MS and our vision to redefine the standard of care for neurological diseases. Learn more:https://medtechbreakthrough.com/2024-winners/

Every person living with multiple sclerosis (MS) is unique and there are limited tools available that measure disease activity over time.

Octave’s Multiple Sclerosis Disease Activity (MSDA) Test enables clinicians to measure this activity through a simple blood test that gives a numeric score to measure and track disease activity over time.

Learn more about Octave’s MSDA test and the Precision Care Solution: https://www.octavebio.com/octave-msda-informational-video/

Octave MSDA Informational Video - Octave Bio

Join Olink Proteomics and Octave at PMWC - Precision Medicine World Conference to hear Ferhan Qureshi, VP of Biomarker Product Development at Octave present "Bridging Proteomics to the Clinic – A Multivariate Blood Test for Disease Activity in Multiple Sclerosis" at 9:45 a.m. PT on Thursday, Jan. 25 in the Showcase Track S2.

Learn more ➡️ https://bit.ly/480X8Jr